On fire! Firebrick (ASX:FRE) share price surges another 22% on second day of trade

Investors are bidding up the share price of this pharmaceutical small-cap today…

| More on:
A graph ablaze with fire going up, indicating a fired up and surged share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Firebrick Pharma share price is up an additional 22% today
  • Shares in the company reached a new all-time high of 75 cents a piece
  • Investors take a chance on the pre-revenue nasal spray developer

The Firebrick Pharma Limited (ASX: FRE) share price is figuratively on fire once again on Monday. Continuing its green streak following its successful initial public offering (IPO) and listing on Friday, Firebrick is soaring again on its second day of trading.

At the time of writing, shares in the nasal spray developer are up 22.6% to 65 cents per share. However, earlier in trade the company had reached a new all-time high of 75 cents per share.

The further surge in the newly listed pharmaceutical company's valuation now prices it 3.25 times higher than its original offer price.

What's going on with the Firebrick share price today?

The excitement surrounding Firebrick's debut on the ASX has extended into Monday following the weekend. However, there is no new information today that we didn't already know on Friday. Instead, it appears the market is still grappling with what fair value is for the company's shares.

We covered Firebrick's IPO previously, but for a quick refresher — the company has developed its patented Nasodine nasal spray product. This medicine is targeted to treat viruses that cause the common cold via the nose. Currently, the company's product is in clinical trials, with plans to have it approved by regulators in the future.

Additionally, Firebrick's interest in testing the nasal spray against COVID-19 likely has garnered added attention from investors. This will be conducted in a phase 2 clinical trial this year. Fortunately, the company now has $7 million in its piggy bank to fund these trials following its IPO.

Nonetheless, the volatility in the Firebrick share price is likely partly attributable to the pre-revenue nature of the business.

According to the prospectus, the company's income for the year ended 30 June 2021 totalled ~$423,000. This was predominantly from a research and development tax rebate. Meanwhile, expenses rounded out at around $2.86 million for the period. As a result, Firebrick burnt $2.44 million in FY21.

Based on the current Firebrick share price, the pharmaceutical company is valued at $69 million.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why DroneShield, Healius, Newmont, and Paragon Care shares are pushing higher

These ASX shares are having a strong session on Tuesday. But why?

Read more »

Miner looking at a tablet.
Share Gainers

Guess which ASX lithium stock just surged 94% on a deal with Mineral Resources

Investors are sending the ASX lithium stock rocketing following a joint venture agreement with Mineral Resources.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

It's not too late to buy these 2 rocketing ASX 200 stocks

These dividend shares produce a handy income at the same time as racking up capital gains.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Share Gainers

2 ASX shares with 'promising growth prospects' just starting to creep up now

You need to dump the false logic that stocks that have already moved up are less likely to go further.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild day for ASX 200 shares, with a new record high.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Share Gainers

Why Calix, Genex, Life360, and Spartan Resources shares are rising

These ASX shares are starting the week on a positive note. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Core Lithium, Life360, Syrah, and Xero shares are jumping today

These ASX shares are ending the week on a high. But why?

Read more »

Smiling elderly couple looking at their superannuation account, symbolising retirement.
Share Gainers

These were the best performing ASX 200 shares in February

These shares were making their shareholders smile last month.

Read more »